Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations

MLA

Lacour, Robin A., et al. “Improved Survival in Non-Ashkenazi Jewish Ovarian Cancer Patients with BRCA1 and BRCA2 Gene Mutations.” Gynecologic Oncology, vol. 121, no. 2, May 2011, pp. 358–63. EBSCOhost, https://doi.org/10.1016/j.ygyno.2010.12.354.

APA

Lacour, R. A., Westin, S. N., Meyer, L. A., Wingo, S. N., Schorge, J. O., Brooks, R., Mutch, D., Molina, A., Sutphen, R., Barnes, M., Elder, J., Teoh, D., Powell, C. B., Choubey, V., Blank, S., MacDonald, H. R., Brady, M. F., Urbauer, D. L., Bodurka, D., & Gershenson, D. M. (2011). Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations. Gynecologic Oncology, 121(2), 358–363. https://doi.org/10.1016/j.ygyno.2010.12.354

Chicago

Lacour, Robin A., Shannon N. Westin, Larissa A. Meyer, Shana N. Wingo, John O. Schorge, Rebecca Brooks, David Mutch, et al. 2011. “Improved Survival in Non-Ashkenazi Jewish Ovarian Cancer Patients with BRCA1 and BRCA2 Gene Mutations.” Gynecologic Oncology 121 (2): 358–63. doi:10.1016/j.ygyno.2010.12.354.